Compare Eli Lilly And Co (LLY) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Packaging Corporation of America — how do they compare? Eli Lilly And Co trades at $1,177.77 (market cap $1.04T), while Packaging Corporation of America trades at $230.51 (market cap $20.49B). The key difference: Eli Lilly And Co is far larger — about 50.8× Packaging Corporation of America's market cap, and Packaging Corporation of America pays the higher dividend (2.61%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Packaging Corporation of America for 45 Days on average.
| LLY | PKG | |
|---|---|---|
Market Cap | $1.04T | $20.49B |
Volume | 3,064,878 | 493,499 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.28K | $257.43 |
52-Week Low | $799.57 | $191.68 |
Typical Hold Time | 93 Days | 45 Days |
Enterprise Value | $1.09T | $24.30B |
Dividend Yield | 0.59% | 2.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
Packaging Corporation of America (PKG) trades at $230.51, up 1.43% on the day, amid a bearish technical signal from moving averages and oscillators. Recent earnings show mixed results with Q2 2026 beating estimates but Q4 2025 missing, while revenue growth is projected from $9.0B in 2025 to $9.5B in 2026. The company maintains a solid dividend, declaring $1.50 per share payable in October 2026, and analyst consensus leans hold with a $272.43 price target.
PKG faces headwinds from cost pressures and negative net cash flow, but strong institutional interest and stable packaging demand offer support. Risks include margin compression and economic sensitivity, yet the stock's current discount to analyst targets presents a potential upside for patient investors focused on fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
